MLSS Milestone Scientific Inc. Total Debt to Capital

MLSS (Milestone Scientific) - company brandmark

Milestone Scientific (MLSS) serves as a technological leader in precision anesthesia administration utilizing Wand/STA AI systems. This price chart on the GURU.Markets platform shows that the debt-to-equity ratio is 0.19. The company faces a liquidity shortage due to inertia in the dental market, while its developments support environmental sustainability by minimizing pharmaceutical waste.

Debt to Equity Ratio: milestonescientific.com (MLSS) for 07/04/2022 - 10/27/2026

Analytical breakdowns and data insights for company Milestone Scientific Corporation (MLSS)

- price and consensus price forecast:
Price Chart Milestone Scientific Inc.|MLSS - Consensus Target
- market capitalization data:
Market Capitalization Milestone Scientific|MLSS - Total Enterprise Value
- book capitalization data:
Book Value per Share Milestone Scientific|MLSS - Accounting Capitalization|Market Capitalization to Book Value Ratio milestonescientific.com|MLSS - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital Milestone Scientific|MLSS - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Milestone Scientific|MLSS - Company Aggregate Debts|Debt to Book Capitalization Ratio Milestone Scientific
Summary company analysis:MLSS, Milestone Scientific Inc.
Brand item of Milestone Scientific Corporation

To objectively assess the stability of Milestone Scientific (MLSS), investors must compare capital growth rates with the volume of debt obligations. Analyzing the company's history of debt leverage reveals the ratio of total debt to equity, which, combined with recurring revenue from the sale of consumables, confirms the business's ability to service loans through a stable free cash flow.

Analysis of competing companies

Debt to Equity ISRG|Total Debt to Equity Ratio Danaher Corporation|Becton, Dickinson and Company - Total Debt to Capital|Debt to Capital STERIS Group (STE)|WST - Total Debt to Capital|Debt to Equity Ratio baxter.com BAX|Total Debt to Capital MASI (Masimo)|STVN - Total Debt to Capital Coefficient|TFX (Teleflex Inc) - Total Debt to Capital|Merit Medical Corp (MMSI) - Total Debt to Equity Ratio|NVST (Envista Holdings) - Total Debt to Capital|Total Debt to Capital ICUI|Debt to Equity Dentsply Sirona (XRAY)|Debt to Equity LeMaitre Vascular Inc LMAT|Total Debt to Equity Ratio AtriCure Corp|All Debt to Shareholders' Equity Ratio STAAR Surgical Co STAA|Total Debt to Capital NAGE (ChromaDex Corp.)|ZIMV: Total Debt to Capital Coefficient|Debt to Equity AngioDynamics|CERS (Cerus Corp.) - Debt to Equity Ratio|TKNO: Debt to Equity|Total Debt to Capital Coefficient Monogram Orthopedics Inc. (MGRM)|Total Debt to Equity Ratio Sharps Technology, Inc.|Aggregate Debt to Capital INFU (infusystem.com)|Debt to Equity Utah Medical Products, Inc.|KRMD - All Debt to Shareholders' Equity Ratio|Nyxoah, S.A. - Total Debt to Equity Ratio|MBOT: Total Debt to Capital|PDEX (Pro-Dex, Inc.) - Debt to Equity|zentek.com (ZTEK) - Total Debt to Equity Ratio|Total Debt to Capital ELUT (Elutia)|Debt to Capital NXGL|Debt to Equity Retractable Technologies RVP|Debt to Equity Ratio harvardbioscience.com HBIO|Total Debt to Equity Ratio Femasys Inc. (FEMY)|Meihua Medical Technologies - Aggregate Debt to Capital|Debt to Equity POAI (Predictive Oncology Corp)|CJMB: Total Debt to Capital Coefficient|ATRI (Atrion Corp) - Debt to Equity|NeuroMetrix Corporation (NURO) - Total Debt to Equity Ratio